Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.646076
Abstract: There are no FDA-approved drugs to mitigate the delayed effects of radiation exposure that may occur after a radiological attack or nuclear accident. To date, angiotensin-converting enzyme inhibitors are one of the most successful candidates… read more here.
Keywords: increases bioavailability; bioavailability lisinopril; radiation increases; lisinopril ... See more keywords